Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.

Sarah Hamdy AhmedMohamed Atef AlMoslemanyKenneth Whitaker WitwerAhmed Gamal TehamyNagwa El-Badri

Published in: Stem cell reviews and reports (2024)

Similar to their parental cells, stem cell EVs mediate lung tissue regeneration by targeting multiple pathways and thus hold promise in promoting the recovery of COVID-19 patients and improving the survival rate of severely affected patients.

Keyphrases

stem cells
sars cov
end stage renal disease
newly diagnosed
induced apoptosis
ejection fraction
cell therapy
chronic kidney disease
small molecule
peritoneal dialysis
prognostic factors
big data
machine learning
endoplasmic reticulum stress
free survival
coronavirus disease